Jaime Baquero
Neurology with Special Qualifications in Child Neurology · Boca Raton, FLNPI 1497779474
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 148 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by UCB, Inc. at 27.6% of the total. Reporting peaked in 2019 at $1,388 and has fallen 78.6% since, to $298 in 2025.
Across 148 payments — averaging $30.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$1K
- Supernus Pharmaceuticals, Inc.$597
- Eisai Inc.$436
- Neurelis, Inc.$386
- Corium, LLC$241
- Ironshore Pharmaceuticals Inc.$210
- plus $1K from 22 others
What the payments were for
- Food & beverage$4,38098%
- Education$732%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 35 | $1,231 |
| Supernus Pharmaceuticals, Inc. | 17 | $597 |
| Eisai Inc. | 11 | $436 |
| Neurelis, Inc. | 10 | $386 |
| Corium, LLC | 13 | $241 |
| Ironshore Pharmaceuticals Inc. | 6 | $210 |
| Aquestive Therapeutics, Inc. | 12 | $186 |
| Jazz Pharmaceuticals Inc. | 3 | $145 |
| Livanova USA, Inc. | 1 | $142 |
| Sunovion Pharmaceuticals Inc. | 7 | $138 |
| Biogen | 2 | $117 |
| Genentech USA, Inc. | 3 | $88 |
| Neos Therapeutics, LP | 5 | $74 |
| Johnson & Johnson | 1 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Novartis | 3 | $49 |
| Tris Pharma Inc | 3 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Pfizer | 1 | $31 |
| Ceribell, Inc. | 1 | $30 |
| Insulet Corporation | 1 | $30 |
| Adlon Therapeutics L.p. | 1 | $22 |
| Shire North American Group Inc | 1 | $20 |
| Acadia Pharmaceuticals Inc | 1 | $18 |
| Eton Pharmaceuticals, Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| Medtronic | 1 | $13 |
| Travere Therapeutics, Inc. | 2 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,453 in reported general payments places this provider in the 55th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
See all neurology with special qualifications in child neurology providers in Florida →
Other neurology with special qualifications in child neurology in Boca Raton
- Romeo FernandezBoca Raton$17K
- Paul WinnerWest Palm Beach$624K
- Omer Abdul HamidOrlando$283K
- Natalie GillsonFort Myers$250K
- Trevor ResnickMiami$230K
- Migvis MonduyMiami$188K
- Elza VasconcellosMiami$170K
- Ronald DavisWinter Park$154K
- Ian MillerMiami$104K
- Michael HammerSaint Petersburg$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.